Research article · 2013
Conference abstractPublished 13 Jul 2018
Pediatric ceftriaxone dose rounding protocol
Community Health Network, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Ceftriaxone is a 3rd generation cephalosporin that works by binding to penicillin binding proteins to inhibit bacterial cell wall synthesis. Ceftriaxone is commonly used to treat infections caused by S.pneumoniae such as community-acquired pneumonia or meningitis and E.coli which is commonly identified in urinary tract infections. Ceftriaxone is widely distributed in the lungs, bone, bile, and CSF. It is primarily excreted unchanged in the urine. Ceftriaxone exhibits timedependent bactericidal activity. Patient-specific doses for ceftriaxone are labor intensive to prepare in the central pharmacy. Doses between 1g and 2g are unable to be reused if the patient’s medication is discontinued after the dose is prepared. Doses of 1g or 2g can be stored properly and reused prior to the beyond use date. The purpose of this protocol is to round ceftriaxone doses to minimize errors and waste while maintaining appropriate doses. Discussion: A study in a children’s medical center looked at improving pediatric outcomes through medication standardization. By implementing these changes, the pharmacy was able to increase productive interdisciplinary communication, decrease errors and expedite medication procurement. A second study evaluated antibiotic dosing errors in pediatric patients before and after implementation of a standard dosing table, which included ceftriaxone. The antibiotic dosing standardization significantly reduced the incidence of dosing errors for inpatient pediatric patients from 65.8% to 5.06%. Findings: Pharmacist will automatically adjust the final dose per the dose rounding table. Conclusion & Significance: This protocol applies to the pediatric patients weighing >20kg at Community Health Network. Patients <20kg will follow standard dosing and medication dispensing per current practice. The dose-rounding table provides dosing that is potentially greater than the 5% variance approved by pharmacy policy but is within appropriate dosing ranges for the various indications.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Single daily dosing of Ceftriaxone and Metronidazole is as safe and effective as Ampicillin, Gentamicin and Metronidazole for non-operative management of complicated appendicitis in children
Research article · 2011
Grand Rounds in Pediatric Nephrology
Case report · 2010
Grand Rounds in Pediatric Endocrinology
Conference abstract · 20 May 2019
Evaluation of hospital wide implementation of aminoglycoside once daily dosing protocol in pediatrics
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Positive outcome in a patient with hypoplastic left heart syndrome: Key factors for successful survival: A case report
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Sarah S Nierman”

